SUBSCRIBE
SUBSCRIBE

Phase I

For Sale: Pfizer's $3.4 Billion Consumer Healthcare Business
Drug Development
The FDA Calls Pfizer’s Next-Generation Lung Cancer Drug a Breakthrough
April 27, 2017
 · 
3 min read
Biotech Bay
Top 15 R&D Spenders In The World For 2017
April 24, 2017
 · 
1 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Why Former Medivation CEO and a Once-Failed Alzheimer’s Drug Could be a Recipe for Disaster for Axovant
April 19, 2017
 · 
3 min read
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine
Drug Development
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine
April 17, 2017
 · 
3 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
When It Rains, It Pours: Bay Area’s OncoMed Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study
April 17, 2017
 · 
2 min read
Drug Development
Flugen, Inc. Raises $2M More, Provides Update on Phase I Trial
April 12, 2017
 · 
1 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
3 Drug Giants That Boasts the Best Pipelines
April 10, 2017
 · 
3 min read
Drug Development
Gazing Into The Crystal Ball For Advaxis: What To Expect At ASCO 2017
April 7, 2017
 · 
1 min read
Bristol-Myers Squibb's Stock Topples as Kidney Cancer Drug Flunks Phase III Study
Drug Development
Bristol-Myers Squibb’s Next Big Bet After Opdivo Failure—IDOs
April 4, 2017
 · 
2 min read
Drug Development
Common Antibiotic May Help To Prevent Or Treat PTSD, University of Zurich Study Reveals
April 4, 2017
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Monopar Announces Encouraging Camsirubicin Phase 1b Trial Update
June 1, 2023
 · 
5 min read
Drug Development
Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders
May 31, 2023
 · 
3 min read
Drug Development
Adiso Therapeutics Announces the Completion of a Phase 1b Multiple Ascending Dose Study of ADS051 for the Treatment of Moderately-to-Severely Active Ulcerative Colitis
May 31, 2023
 · 
3 min read
Drug Development
Nacuity Pharmaceuticals Achieves Target Enrollment for Phase 1/2 Clinical Trial of NPI-001 for the Treatment of Retinitis Pigmentosa Associated with Usher Syndrome
May 31, 2023
 · 
3 min read
Drug Development
Myrtelle to Present Positive 6-month Post-Treatment Data in Its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy in Canavan Disease at the National Tay-Sachs and Allied Diseases Annual Family Conference
May 31, 2023
 · 
6 min read
Drug Development
Halberd CEO Mid-Quarter Update
May 31, 2023
 · 
4 min read
Drug Development
Cocrystal Pharma Receives HREC Approval to Initiate Phase 1 Study to Evaluate Oral Broad-Spectrum Coronavirus 3CL Protease Inhibitor CDI-988
May 31, 2023
 · 
4 min read
Drug Development
Celldex Announces First Patient Dosed in Phase 1 Study of CDX-585 in Patients with Advanced Malignancies
May 31, 2023
 · 
6 min read
Drug Development
Glyscend Therapeutics Announces Positive Topline Phase 2a Clinical Results and Progress with GLY-200, a First-in-Class Treatment for Type 2 Diabetes and Obesity
May 31, 2023
 · 
8 min read
Drug Development
KAHR Reports Dose Escalation Results from Phase I Trial of DSP107 in Combination with anti-PD-L1 in Patients with Advanced Solid Tumors
May 31, 2023
 · 
4 min read
Drug Development
Travere Therapeutics Announces Positive Topline Results from Cohort 6 in the Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria
May 31, 2023
 · 
12 min read
Drug Development
Jnana Therapeutics Reports Positive Topline Results from Phase 1a Clinical Study of JNT-517, a Potential First-in-Class Oral Treatment for PKU
May 31, 2023
 · 
4 min read
Drug Development
Coave Therapeutics announces Positive 12-months Data from Ongoing Phase I/II Clinical Trial of CTx-PDE6b in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b
May 31, 2023
 · 
5 min read
Drug Development
BiomX to Present Part 1 Data from Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis During Late-Breaking Science Session at the 46th ECFC
May 31, 2023
 · 
3 min read
Drug Development
IRLAB has Activated all 38 Study Sites in the Phase IIb Study of Pirepemat Aiming to Improve Balance and Reduce Falls in Parkinson’s Disease
May 31, 2023
 · 
4 min read
Drug Development
Xencor Presents Clinical Results from Phase 1a Study of XmAb®564 at the EULAR 2023 Congress
May 30, 2023
 · 
5 min read
Drug Development
PepGen Inc. Announces Clinical Hold in the U.S. on IND Application to Initiate a Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
May 30, 2023
 · 
5 min read
Drug Development
ConSynance Therapeutics Reports Positive Phase 1 Results for CSTI-500 in Prader-Willi Syndrome Patients
May 30, 2023
 · 
3 min read
Drug Development
DEBIOPHARM LAUNCHES PHASE 1 RESEARCH IN SMALL CELL LUNG CANCER WITH WEE1 INHIBITOR DEBIO 0123 TO OUTSMART DDR IN SMALL CELL LUNG CANCER
May 30, 2023
 · 
5 min read
Drug Development
A2 Bio Announces First Patient Dosed in Phase 1 Clinical Trial of A2B530, a Novel Cell Therapy for the Treatment of Colorectal, Pancreatic and Non-small Cell Lung Cancers
May 30, 2023
 · 
3 min read
Load More